Felbamate - Merck
At a glance
- Drug Originator Meda Pharmaceuticals
- Drug Licenced by AESCA; Essex Chemie; Merck & Co
- Drug Class Antiepileptic drugs; Phenylcarbamates; Propylene glycols; Small molecules
- Mechanism of Action NMDA receptor antagonists
- USA Patent Applicants MYLAN SPECIALITY LP
- USA Patents 2
- NDAs 1
- Patent Applications 4,194
Table of Contents
Disclaimer